Navigation Links
Powerful Anti-breast-cancer Pill on the Anvil

The US Food and Drug Administration (FDA) has granted marketing approval to pharmaceutical giant GlaxoSmithKline for its breast cancer// pill Tykerb.

It has been claimed that Tykerb is far more potent in combating advanced stages of breast cancer than the drugs currently available for the purpose.

Breast cancer is the second leading cause of cancer deaths in women worldwide. According to statistics, about a million new cases are expected to occur this year itself. Analysts reckon Tykerb could be generating 1 billion US dollars in sales by 2010. By then, it is likely to be approved for wider breast cancer indications, and other cancer types such as head and neck and renal. Further trials are underway.

Tykerb seeks to specifically target cancer-causing proteins and more effective than other new generation drugs of the genre like Herceptin.

Experts note that Herceptin has been found to have a lot of limitations, some cancers become resistant to it even. Also while Herceptin is injectible Tykerb is a pill.

Even more important, it has no side-effects, of the cardiovascular type seen in other drugs, according to Dr.K.Geeta, a surgeon attached to the Rajiv Gandhi Cancer Institute, New Delhi.

However, industry sources warn that it would be prohibitively expensive and would require governmental intervention to make it affordable for the average Indian.
'"/>




Page: 1

Related medicine news :

1. Direct To Home: Television Provides Powerful Fillip to Smoking Cessation Campaigns.
2. Figment of Imagination? A Powerful US Economy Gives Rise to Fatal Heart Attacks
3. AIDS – A Powerful Mankille
4. Powerful Synergy: Botswana and Clinton foundation To Sign MOU
5. A New Study Finds Chocolate Milk Powerful Than Sports Drinks
6. Scientists Come Up With A Powerful Weapon To Fight Drug Resistant Bacteria
7. Powerful New IVF Treatment Promises Better Results
8. MEG Scanners Are Mega Powerful
9. Learning Words by Inference More Powerful for Toddlers
10. Crusade Against Cancer: Collaborations On The Anvil
11. New Drug For Oral Cancer Detection On The Anvil
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/6/2016)... ... May 06, 2016 , ... Norwood Insurance Group, serving ... beneficiary of their ongoing community enrichment program. The current campaign is being extended ... faces many more months of treatments, leaving his family in great need of ...
(Date:5/6/2016)... ... May 06, 2016 , ... US Sports Camps has ... camp held at Oregon State University this summer. Employing world-class rugby figures, including former ... all skill levels with training on key fundamentals, match play, fitness and more. , ...
(Date:5/6/2016)... ... ... Logically, spring weather, with its moderate humidity and temperatures, should be ideal ... hot, water on the eye surface can evaporate, creating uncomfortable dry eye symptoms. In ... one problem, according to radio show and water advocate Sharon Kleyne: Spring is also ...
(Date:5/6/2016)... ... May 06, 2016 , ... The International Yoga Teacher Training schoo ... of the island close to the town famous for its sunsets, Oia. This all ... “We continue to have an amazing experience in Greece, we just can’t stay away” ...
(Date:5/6/2016)... ... 2016 , ... In honor of Military Spouse Appreciation Day ... the National Military Family Association, a nonprofit that works to strengthen and protect ... recipient of 2016. , “Being awarded this scholarship by Career Step, is ...
Breaking Medicine News(10 mins):
(Date:5/5/2016)... 2016 Global NASH market ... with rise in obesity will fuel the demand ... few years. The NASH Market is growing at ... account of rising number of obesity among young ... market with no FDA approved therapeutics. Antioxidants, anti-diabetic ...
(Date:5/5/2016)... DUBLIN , May 5, 2016  Endo ... ENL) today announced that Brian Lortie , ... down from his position upon the appointment of ... and led its U.S. Pharmaceuticals business with responsibility ... sales and marketing, strategy and portfolio development, commercial ...
(Date:5/5/2016)... 2016 , First quarter 2016 ... of $964 million , First quarter reported ... , Company revises 2016 financial guidance; now ... billion and 2016 adjusted diluted non-GAAP earnings per share to ... provides updates regarding Generics business and manufacturing facility restructuring ...
Breaking Medicine Technology: